Vulnerabilities

Vulnerability · CVE-2026-3689

OpenClaw Canvas Path Traversal Information Disclosure Vulnerability.

Published Apr 11, 2026 · catalog updated Jun 17, 2026 · OpenClaw Canvas Path Traversal

Check if you run it

No confirmed exploitation is on record for CVE-2026-3689. EPSS is 0.96%. Act only if a listed version of OpenClaw Canvas Path Traversal is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (OpenClaw Canvas Path Traversal).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium6.5
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.96%
Remediation
Advisory link
Affected products
cpe openclaw/openclaw

OpenClaw Canvas Path Traversal Information Disclosure Vulnerability. This vulnerability allows remote attackers to disclose sensitive information on affected installations of OpenClaw. Authentication is required to exploit this vulnerability. The specific flaw exists within the handling of the path parameters provided to the canvas gateway endpoint. The issue results from the lack of proper validation of a user-supplied path prior to using it in file operations. An attacker can leverage this vulnerability to disclose information in the context of the service account. Was ZDI-CAN-29312.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe openclaw/openclawversion unspecified

How to fix CVE-2026-3689

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-3689. EPSS is 0.96%. Act only if a listed version of OpenClaw Canvas Path Traversal is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-22: Path Traversal. EPSS 0.96%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Apr 11, 2026 · NIST NVD

    Detected

    OpenClaw Canvas Path Traversal Information Disclosure Vulnerability. This vulnerability allows remote attackers to disclose sensitive information on affected installations of OpenClaw. Authentication is required to exploit this vulnerability. The specific flaw exists within the handling of the path parameters provided to the canvas gateway endpoint. The issue results from the lack of proper valida

  2. Jun 17, 2026 · NIST NVD

    Updated

    OpenClaw Canvas Path Traversal Information Disclosure Vulnerability. This vulnerability allows remote attackers to disclose sensitive information on affected installations of OpenClaw. Authentication is required to exploit this vulnerability. The specific flaw exists within the handling of the path parameters provided to the canvas gateway endpoint. The issue results from the lack of proper valida

Sources

  • CVE.orgVulnerability recordCVE-2026-3689

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-3689

    30-day exploitation probability 1.0%

    first.org
  • NIST NVDVulnerability recordCVE-2026-3689

    OpenClaw Canvas Path Traversal Information Disclosure Vulnerability. This vulnerability allows remote attackers to disclose sensitive information on affected installations of OpenClaw. Authentication is required to exploit this vulnerability. The specific flaw exists within the

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.